qi5 Citations (5)

Originally described in: Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.
Conklin BR, Farfel Z, Lustig KD, Julius D, Bourne HR Nature. 1993 May 20. 363(6426):274-6. PubMed Journal

---

Articles Citing qi5

Articles
Differential expression and HIV-1 regulation of mu-opioid receptor splice variants across human central nervous system cell types. Dever SM, Xu R, Fitting S, Knapp PE, Hauser KF. J Neurovirol. 2012 Jun;18(3):181-90. doi: 10.1007/s13365-012-0096-z. Epub 2012 Apr 20. PubMed
Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4. Peeler JC, Schedin-Weiss S, Soula M, Kazmi MA, Sakmar TP. J Biol Chem. 2017 Dec 29;292(52):21623-21630. doi: 10.1074/jbc.M116.758961. Epub 2017 Nov 3. PubMed
Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2. Morita K, He S, Nowak RP, Wang J, Zimmerman MW, Fu C, Durbin AD, Martel MW, Prutsch N, Gray NS, Fischer ES, Look AT. Cell. 2020 Apr 30;181(3):702-715.e20. doi: 10.1016/j.cell.2020.03.051. Epub 2020 Apr 20. PubMed
Highly Selective Y4 Receptor Antagonist Binds in an Allosteric Binding Pocket. Schuss C, Vu O, Schubert M, Du Y, Mishra NM, Tough IR, Stichel J, Weaver CD, Emmitte KA, Cox HM, Meiler J, Beck-Sickinger AG. J Med Chem. 2021 Mar 11;64(5):2801-2814. doi: 10.1021/acs.jmedchem.0c02000. Epub 2021 Feb 17. PubMed
Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y(4) Receptor Positive Allosteric Modulator VU0506013. Schuss C, Vu O, Mishra NM, Tough IR, Du Y, Stichel J, Cox HM, Weaver CD, Meiler J, Emmitte KA, Beck-Sickinger AG. J Med Chem. 2023 Jul 13;66(13):8745-8766. doi: 10.1021/acs.jmedchem.3c00383. Epub 2023 Jun 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.